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In the articles published in this
specialissuecommemoratingacen-
tennial of the Bolshevik Revolu-
tion, the contributors examine
certain illuminating episodes in the
history of the Soviet zdravookhranenie,
analyze its influence on concur-
rent public health ideas of in-
fluential international players,




USSR” by Starks (p. 1718) de-
scribes the challenges faced by
Narkomzdrav in its attempts to
introduce the Bolshevik visions of
health and disease to the coun-
try’s still largely illiterate and ig-
norant population, who were
suspicious of modern medicine,
through extensive education and
propaganda campaigns. An
elaborate poster was produced
for the 10th anniversary of the
Bolshevik Revolution and cele-
brated Narkomzdrav’s perceived
successes in fulfilling itsmission of
protecting the health of the
people. It serves as a convenient
entry and a striking visual aid to
Starks’s analysis of the participants,
goals, scope, means, targets, and
results of these campaigns that
spread the message of healthy
lifestyles and disease prevention.
In “A Revolutionary Attack
on Tobacco,” Starks (p. 1711)
details the Narkomzdrav ap-
proach to tobacco as a health
hazard and the agency’s pio-
neering efforts to curb its use on





derailed the agency’s attempts to
limit tobacco cultivation, pro-
duction, and sales. Morabia’s
editorial (p. 1708) places Starks’s
analysis in a broader interna-
tional context by comparing the
Bolsheviks’ and the Nazis’ atti-
tudes toward tobacco.
Grant’s contribution (p. 1725)
illuminates an important but
little studied part of the Soviet
health care system, nursing. It
traces the historical development
of nursing in Russia and addresses
continuities and changes in the
social status, training, self-image,
numbers, and roles of nurses in the
transition from the imperial to the
Soviet and then from the Soviet to
the post-Soviet systems of health
protection.
Rivkin-Fish (p. 1731) ex-
amines direct and indirect lega-
cies of Soviet zdravookhranenie in
contemporary Russian policies
regarding addiction, HIV, and
abortion. Her article surveys the
preservation of certain Soviet
patterns in doctor–patient re-
lations, institutional structures,
and ideological strictures in the
health system of Putin’s Russia
and explores the varying uses of
the Soviet past in articulating,
validating, and promoting con-
temporary policies.
In addition to these analytical
essays, two “Voices from the
Past” articles present the obser-
vations and immediate impres-
sions of the Soviet health system
by two highly influential West-
ern experts who visited the coun-
try after the Bolsheviks had come
to power.
The first voice (p. 1740) be-
longs to Alan Gregg, a high-
ranking officer of theRockefeller
Foundation Medical Education
Division, and is extracted from
a daily journal Gregg kept during
his fact-finding trip to Moscow
and Leningrad in December
1927, less than a month after the
nationwide public celebrations of
the 10th anniversary of the rev-
olution. Although his official
mandate was limited to exploring
possibilities of cooperation be-
tween Narkomzdrav and the
Rockefeller Foundation in the
specific area of medical educa-
tion, Gregg’s diary provides a
panoramic, although necessarily
telegraphic, view of Soviet
zdravookhranenie. Gregg recorded
his conversations with its key
figures, ranging from Commissar
Semashko and his underlings
to the leading lights of Soviet
clinical medicine and biomedical
research.
The second voice (p. 1736)
belongs to Henry E. Sigerist, a
leading Swiss American historian
of medicine and health system
analyst, and comes from his 1937
book Socialized Medicine in the
Soviet Union. Sigerist had spent
several months in the country
two years before, and his book
presented his thoughts and anal-
ysis of the health care system he
had carefully studied and came to
admire.
Taken together, the analytical
essays and witness testimonies
offer an instructive, if somewhat
kaleidoscopic, glimpse at the
promises, realities, and legacies of
a unique experiment in creating
an integrated, universally acces-
sible, state-run health system in-
augurated by the Bolshevik
Revolution a century ago.
Nikolai Krementsov, PhD
Assessing the Public Health Impact of
the mHealth App Business
See also Millington, p. 1696, and also Grundy et al.,
p. 1783.
Do mobile health applications
(mHealth apps) promise solutions
to such pressing public health
problems as increasing access to
care, reducing inequalities in
health, lowering health care costs,
and providing people with new
tools to reduce risky behavior and
manage chronic diseases? To an-
swer this question, public health
professionals and researchers need
to examine how the more than
259000 mHealth apps now avail-
able in the US market1 contribute
to improved population health
now and will in the future.
In this issue of AJPH, Grundy
et al. (p. 1783) provide evidence
that may temper the often un-
critically enthusiastic response to
mHealth apps from the media,
business, and some health pro-
fessionals and policymakers. In
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a social network analysis of the
financial relationships among app
developers, investors, funding
sources, and content advisers
of a purposive sample of 491
mHealth apps in theUnited States,
Canada, and Australia, the authors
found several causes for concern.
CAUSES FOR
CONCERN
First, they report that most
best-selling mHealth apps are
developed by private compa-
nies with multiple connections
to larger corporations in the
technology, fashion, entertain-
ment, and pharmaceutical sectors
and with venture capital firms.
Leading developers of health apps
include such major transnational
corporations as Medtronic plc
(Ireland), Koninklijke Philips
N.V. (Netherlands), Google
(US), Omron Corporation (US),
Apple, Inc. (US), LifeWatch AG
(Switzerland),Withings (France),
and Nokia Corporation (Fin-
land). Grundy et al. also note that
the mHealth financial and pro-
duction ecosystem remains
“hidden from public view,”
making it difficult to assess bias
and conflicts of interest. Few
major apps have clearly identified
scientific or clinical advisers, and
these advisers may hold multiple
scientific, clinical, and financial
roles. In the pharmaceutical in-
dustry, these blurred lines have
contributed to the inappropriate
use of medications, withholding
data from regulators, and mis-
leading marketing claims.2
Several broader trends provide
additional causes for concern.
First, the evidence base for safety
and effectiveness of mHealth
apps is thin. In a review of 137
patient-facing mHealth apps,
Singh et al. found that few had
been evaluated, especially for use
by vulnerable populations.3 Only
23% of the tested apps responded
appropriately when a user entered
information that indicated a dan-
ger such as suicidal mood or
ideation. More than a third (36%)
lacked any privacy policy. In ad-
dition, sellers, users, clinicians, and
researchers did not agree in their
ratings of apps, suggesting lack of
consensus on what makes an app
helpful and effective.
Second, mHealth apps have
the potential towiden rather than
reduce inequalities in health.
New technologies often first
benefit the better off. Grundy
et al. note that because health
apps are often monetized and
linked to the promotion of other
products and services, they are
targeted at the “White, worried,
and well” rather than the poor
and underserved (p. 1783).
For the large corporations that
are expected to dominate the
mHealth market in coming years,1
the focus on profitability shapes
which apps get developed and
which populations will be targeted
in marketing these products.
JEOPARDIZED PUBLIC
HEALTH
These market trends may have
other adverse consequences. As
more businesses enter the field,
the number of new apps is
growing rapidly, with 100 000
new products added in 2016.1 At
the same time, demand, measured
in sales, is slowing, falling from a
35% growth rate in 2015 to 7% in
2016.3 In other business sectors,
the combination of market con-
solidation, increased competition,
and overproduction has jeopar-
dized public health. In the firearm
industry, for example, new tech-
nologies led to overproduction of
mass-manufactured guns, and in-
dustry consolidation left fewer,
bigger companies with more re-
sources for product development
and marketing. The subsequent
drop in demand for firearms from
hunters and sports shooters led the
industry to restore profitability by
developing more lethal weapons
and marketing them aggressively
with fear-based campaigns.4 Sim-
ilar trends have been documented
in tobacco, alcohol, and ultra-
processed food.5
In this case, maintaining prof-
itability as the number of mHealth
apps for sale grows may lead app
developers to make more mis-
leading claims, cover up defects, or
market unscrupulously. The large
companies that are consolidating
control of this market have the
deep pockets needed to invest in
marketing, lobbying, and chal-
lenging public oversight. Already
weak and overlapping regulations,
inadequate funding, and lax en-
forcement limit publicmonitoring
ofmHealth apps. James L.Madara,
chief executive officer of the
American Medical Association,
has called mHealth apps “digital
snake oil,” observing that “though
these products may be well-
intentioned, far too many provide
incomplete or inaccurate snap-
shots of a patient’s health and ul-
timately fail to deliver on their
promises.”6
LACK OF REGULATION
At present, most mHealth
apps available to consumers are
not regulated by the Food and
Drug Administration (unless they
connect to a medical device)
or by the privacy rules of the
Health Insurance Portability and
Accountability Act of 1996.3
Although the Federal Trade
Commission has suggested best
practices on privacy, security, and
truthful claims, it has neither
the expertise nor the staffing to
monitor the marketing practices
of the mHealth apps available in
the United States. In the past few
years, the tech, pharmaceutical,
and fashion companies that are
moving into mHealth apps have
pioneered a wide array of new
marketing strategies. These in-
clude cloaked Web sites that
extoll the virtue of products
without disclosing their corpo-
rate sponsorship, “native adver-
tising,” in which users tout a
product without revealing they
are being rewarded by the
company, and “content market-
ing,” in which digital and tradi-
tional media carry stories
sponsored by producers of
products, sometimes without
disclosure of their role.7 As the
federal government moves to
rescind or defund key public
health regulatory functions,
health app developers seeking to
grow their market share could
promote wider use of untested or
unsafe products.
For universities, mHealth
apps raise other questions. Are
university-based mHealth app
developers required to disclose
their corporate affiliations or re-
port their income? Are they liable
when companies irresponsibly
market products researchers have
developed? Will the lure of
patenting health apps lead re-
searchers to abandon open source
apps, favoring the development
of apps for customers who can
afford them, rather than those
who could benefit most?
NEED FOR EMPIRICAL
EVIDENCE
In the final analysis, new
technologies are neither good
nor bad for health. Neither un-
critical promotion of mHealth
apps nor reflexive Luddite op-
position will help to assess their
long-term impact on health.
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What determines whether
mHealth apps or other emerging
technologies provide net benefit
or harm to health is both the
specific characteristics of the
products and who has the power
to decide how they are deployed.
Public health researchers can
contribute useful evidence in
both domains.
Certainly, empirical evidence
is needed to determine the safety,
benefits, and risks of particular
mHealth apps for specific pop-
ulations. In addition, however, as
Grundy et al. observe, more
evidence is needed on how the
structure, governance, and prac-
tices of the mHealth industry
influence what products are de-
veloped, how and to whom they
are marketed, and to what extent
they contribute to improving
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Health: An Optimal Commodity for
the Attention Economy
See also Freudenberg, p. 1694, and also Grundy et al.,
p. 1783.
The media scholars Kathleen
Oswald and JeremyPacker have a
helpful turn of phrase for assessing
our present-day communication
landscape: the media environ-
ment, they say, is devoted
to keeping people “fixed in
transmission”—meaning always
engaged with communication
technologies—as opposed to fixed
on one transmission or broadcast in
particular.1 Tobe sure, industry has
long understood the value of
keeping our attention for pro-
longed periods. But in the past you
eventually turned the television off
and went to another room. The
same was true for radio. Newspa-
pers were read and discarded. To
be fixed in transmission is to
be “switched on” constantly with
the help of mobile technology.
Grundy et al.’s social net-
work analysis of financial relation-
shipsunderpinning thedevelopment
of health and fitness apps
(p. 1783) marks a key step in
understanding how this con-
temporary communication
landscape is evolving in con-
junctionwith our efforts at health




The notion of an “attention
economy” is grounded on the idea
that attention operates like any
other commodity: it can be cap-
tured and sold. The communica-
tion scholar Dallas Smythe’s
concept of the “audience com-
modity” is useful in understanding
how the attention economy
works.2 Smythe begins with
a question: “What is the principal
product of the mass media?”2(p23)
The obvious answers are meaning,
entertainment, education, or other
common outcomes of communi-
cation.But consider the economics
of something like a football
broadcast. The television network
buys the rights to broadcast the
game or a season’s worth of games.
But rather than show the game in
its entirety without breaks, the
network allocates time for com-
mercials as a way of recouping
expenditures and, ultimately, ac-
cruing profit. Commercial spon-
sors pay for the right to show their
products and services to particular
audience demographics; football
and pick-up trucks evidently go
hand in hand. Marketers capitalize
on a captivated audience.
Thus, to the question at hand,
Smythe’s answer is not education
or entertainment but rather au-
dience power: something that is
“produced, sold, purchased and
consumed, it commands a price and
is a commodity.”2(p26[emphasis added])
Said otherwise, Smythe recasts
audience experience as a form
of labor. The simple act of turning
our attention in one particular
direction creates a product that is
ripe for commercial exchange.
Smythe’s work has been
highly influential. But it is also
a product of its time. We are
now fixed in transmission. Our
communication devices are
portable—wearable even—and
content is accessible anywhere
and anytime, as marketers often
emphasize.3 A key function of
these changes is the expansion,
in both geographic and temporal
terms, of the opportunities
industry has to capture our at-
tention. To stick with the
football example, one might
watch the game at home, work,
a bar, or anywhere in between.
Moreover, sensor technology
has enhanced our capacity to
direct our attention in different
directions at one and the same
time. An activity-tracking
wristband effectively directs
the user’s attention to steps
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